24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Conditions Treated Asbestosis Laryngeal Cancer Lung Cancer Ovarian Cancer Pleural Mesothelioma
Hospitals & Clinics
specialties & services
Dr. Helen Ross is a medical oncologist in Phoenix, Arizona. She got her medical degree from Revelle College, and did her internship at University of California, Los Angeles. At the Department of Medicine, University of California, Dr. Ross completed her fellowship in hematology/ocology. She is board certified in both internal medicine and medical oncology. Dr. Ross is currently affiliated with Mayo Clinic – Phoenix and Mayo Clinic – Scottsdale.
Revelle College, University of California, San Diego
Medical School
University of California, Los Angeles
Internship
University of California, Los Angeles
Residency
Department of Medicine, University of California, Los Angeles
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
A new scoring system for predicting survival in patients with non-small cell lung cancer.
Schild SE, Tan AD, Wampfler JA, Ross HJ, Yang P, Sloan JA.
See more >>
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-c
Zinner RG1, Obasaju CK, Spigel DR, Weaver RW, Beck JT, Waterhouse DM, Modiano MR, Hrinczenko B, Nikolinakos PG, Liu J, Koustenis AG, Winfree KB, Melemed SA, Guba SC, Ortuzar WI, Desaiah D, Treat JA, Govindan R, Ross HJ.
See more >>
Past approaches and future directions for targeting tumor hypoxia in squamous cell carcinomas of the head and neck.
Curtis KK, Wong WW, Ross HJ.
See more >>Memberships
American Association for Cancer Research
American Society of Clinical Oncology
